Patents by Inventor Yves A. DeClerck

Yves A. DeClerck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metalloproteinase inhibitor
    Patent number: 7994136
    Abstract: A novel metalloproteinase inhibitor, analogs thereof, polynucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders caused by excessive amounts of metalloproteinase are also disclosed.
    Type: Grant
    Filed: May 19, 1989
    Date of Patent: August 9, 2011
    Assignee: Amgen Inc.
    Inventors: Keith E. Langley, Yves A. DeClerck, Thomas C. Boone
  • Methods for detecting metalloproteinase inhibitors
    Patent number: 7553630
    Abstract: A novel metalloproteinase inhibitor, analogs thereof, polynucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders caused by excessive amounts of metalloproteinase are also disclosed.
    Type: Grant
    Filed: July 19, 2004
    Date of Patent: June 30, 2009
    Assignees: Amgen Inc., Childrens Hospital Los Angeles
    Inventors: Keith E. Langley, Yves A. DeClerck, Thomas C Boone
  • Metalloproteinase inhibitor
    Patent number: 6946264
    Abstract: A novel metalloproteinase inhibitor, analogs thereof, polynucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders caused by excessive amounts of metalloproteinase are also disclosed.
    Type: Grant
    Filed: March 2, 1995
    Date of Patent: September 20, 2005
    Assignees: Amgen Inc., Childrens Hospital Los Angeles Research Institute
    Inventors: Keith E. Langley, Yves A. DeClerck, Thomas C. Boone
  • Metalloproteinase inhibitor
    Publication number: 20050196390
    Abstract: A novel metalloproteinase inhibitor, analogs thereof, polynucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders caused by excessive amounts of metalloproteinase are also disclosed.
    Type: Application
    Filed: July 19, 2004
    Publication date: September 8, 2005
    Applicants: Amgen Inc., Children's Hospital of Los Angeles
    Inventors: Keith Langley, Yves DeClerck, Thomas Boone
  • Antibodies to the metalloproteinase inhibitor
    Patent number: 6849450
    Abstract: A novel metalloproteinase inhibitor, analogs thereof, polynucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders caused by excessive amounts of metalloproteinase are also disclosed.
    Type: Grant
    Filed: February 21, 1997
    Date of Patent: February 1, 2005
    Assignees: Childrens Hospital of Los Angeles, Amgen Inc.
    Inventors: Keith E. Langley, Yves A. DeClerck, Thomas C. Boone
  • METALLOPROTEINASE INHIBITOR
    Publication number: 20020090654
    Abstract: A novel metalloproteinase inhibitor, analogs thereof, polynucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders caused by excessive amounts of metalloproteinase are also disclosed.
    Type: Application
    Filed: February 21, 1997
    Publication date: July 11, 2002
    Inventors: KEITH E. LANGLEY, YVES A. DECLERCK, THOMAS C. BOONE
  • Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor
    Patent number: 5714465
    Abstract: A novel metalloproteinase inhibitor, analogs thereof, polynucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders caused by excessive amounts of metalloproteinase are also disclosed. In particular, a method for inhibiting tumor cell dissemination in a mammal comprising administering an effective amount of such metalloproteinase inhibitors is described.
    Type: Grant
    Filed: March 11, 1994
    Date of Patent: February 3, 1998
    Assignee: Amgen Inc.
    Inventors: Keith E. Langley, Yves A. DeClerck, Thomas C. Boone